Company intelligence / Profile preview

TAmiRNA

Vienna, Vienna, Austria
Ownership
Private
Employees
~15
Development stage
Other
01

Overview

TAmiRNA is a biotech company specializing in the discovery and development of microRNA (miRNA) biomarkers for diagnostic and therapeutic applications. The company leverages its proprietary platform to identify miRNA signatures associated with aging-related diseases, including osteoporosis, cardiovascular disorders, and liver disease. TAmiRNA offers a range of diagnostic kits, such as osteomiR for bone health and hepatomiR for liver function, while also advancing a pipeline of miRNA-based therapeutic candidates. By integrating advanced transcriptomics with clinical data, the company aims to provide personalized medicine solutions that improve patient outcomes through early detection and targeted treatment.

Therapeutic areas
CardiovascularMetabolic DisordersEndocrinologyGastroenterologyOncology
Modalities
RNA therapyAntisense oligonucleotideDevice
Industry
Biotech
02

Partnerships

EurofinsMedical University of ViennaUniversity of Natural Resources and Life Sciences (BOKU)

Beyond the preview

Go deeper on TAmiRNA.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TAmiRNA.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call